Published in J Psychopharmacol on January 01, 2000
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.50
Complete atrioventricular block and ventricular tachyarrhythmia associated with donepezil. Emerg Med J (2006) 1.09
Seizures and epilepsy in Alzheimer's disease. CNS Neurosci Ther (2011) 1.05
Models and mechanisms of vascular dementia. Exp Neurol (2015) 0.92
Nantenine as an acetylcholinesterase inhibitor: SAR, enzyme kinetics and molecular modeling investigations. J Enzyme Inhib Med Chem (2010) 0.91
Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology (Berl) (2005) 0.88
Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat (2007) 0.82
Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats. Addict Biol (2012) 0.80
Role of donepezil in autism: its conduciveness in psychopharmacotherapy. Case Rep Psychiatry (2011) 0.79
Donepezil induced antecollis in a patient with Parkinson's disease dementia. Neurol Sci (2012) 0.79
Syncope secondary to second-degree atrioventricular block with donepezil use. Proc (Bayl Univ Med Cent) (2014) 0.76
Effectiveness of rivastigmine on positive, negative, and cognitive symptoms of schizophrenia: a double-blind clinical trial. Ther Adv Psychopharmacol (2016) 0.75
Association between myeloperoxidase levels and risk of coronary artery disease. JAMA (2001) 3.74
Safety of long-term lamotrigine in epilepsy. Epilepsia (1997) 2.92
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance. Pharmacoepidemiol Drug Saf (1997) 2.33
Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation (2001) 2.17
Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports. BMJ (2001) 1.70
Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice. BMJ (2000) 1.62
Prescription-event monitoring of 10,401 patients treated with fluvoxamine. Br J Psychiatry (1994) 1.58
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. BMJ (1988) 1.55
A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients. J Hum Hypertens (2006) 1.51
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br J Clin Pharmacol (1996) 1.47
Prescription-event monitoring and reporting of adverse drug reactions. Lancet (2001) 1.42
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies. Pharmacoepidemiol Drug Saf (1997) 1.38
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England. Br J Obstet Gynaecol (1998) 1.31
Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. Br J Clin Pharmacol (1998) 1.23
Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: characterization by simultaneous transesophageal echocardiography. J Am Coll Cardiol (1993) 1.16
Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol (2001) 1.10
Newer antidepressants: a comparison of tolerability in general practice. Br J Gen Pract (1999) 1.09
The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. J Psychopharmacol (2001) 1.02
United Kingdom experience with alendronate and oesophageal reactions. Br J Gen Pract (1998) 0.94
Differentiation of constrictive pericarditis from restrictive cardiomyopathy by Doppler transesophageal echocardiographic measurements of respiratory variations in pulmonary venous flow. J Am Coll Cardiol (1993) 0.93
Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol (2000) 0.93
Prescription-event monitoring: methodology and recent progress. J Clin Epidemiol (1990) 0.89
Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care (2000) 0.89
Association between SSRIs and upper gastrointestinal bleeding. SSRIs are no more likely than other drugs to cause such bleeding. BMJ (2000) 0.88
Relation of serum triglyceride levels to survival after coronary artery bypass grafting. Am J Cardiol (2000) 0.88
Transesophageal Doppler echocardiography of pulmonary venous flow: a new marker of mitral regurgitation severity. J Am Coll Cardiol (1991) 0.88
ACE-inhibitor-induced cough, an adverse drug reaction unrecognised for several years: studies in prescription-event monitoring. Eur J Clin Pharmacol (1996) 0.86
Cough and angiotensin II receptor antagonists: cause or confounding? Br J Clin Pharmacol (1999) 0.86
Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine. J Psychopharmacol (2001) 0.86
HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from The Cleveland Clinic Foundation. Circulation (2000) 0.85
Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997. Eur J Clin Pharmacol (2001) 0.85
QT lengthening and life-threatening arrhythmias associated with fexofenadine. Br J Gen Pract (2000) 0.83
Effects of mitral stenosis on pulmonary venous flow as measured by Doppler transesophageal echocardiography. Am J Cardiol (1993) 0.82
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring. Drug Saf (2001) 0.80
Front line workers in long-term care: the effect of educational interventions and stabilization of staffing ratios on turnover and absenteeism. J Am Med Dir Assoc (2003) 0.78
A comparison of two cohort studies evaluating the safety of cisapride: Prescription-Event Monitoring and a large phase IV study. Eur J Clin Pharmacol (1997) 0.78
Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis. Atherosclerosis (2000) 0.78
Vasodilation-related adverse events in diltiazem and dihydropyridine calcium antagonists studied by prescription-event monitoring. Eur J Clin Pharmacol (1995) 0.78
Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting. J Heart Valve Dis (2001) 0.78
Comparison of Doppler and two-dimensional echocardiography for assessment of pericardial effusion. Am J Cardiol (1992) 0.78
Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting. Drug Saf (2001) 0.76
How deadly is the "deadly quartet"? A post-CABG evaluation. J Am Coll Cardiol (2000) 0.76
Incompleteness of lamotrigine data. Drug Saf (2001) 0.75
Galactorrhoea with moclobemide. Lancet (1998) 0.75
Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event Monitoring. Int J Clin Pharmacol Ther (1995) 0.75
Fourier series approach to synthesis. Appl Opt (1983) 0.75
Group therapy in the management of manic-depressive illness. Am J Psychother (1981) 0.75
Usefulness of providing physicians the results of risk factor assessments and treatment recommendations at discharge after coronary artery bypass grafting. Am J Cardiol (2000) 0.75
Analysis of grating-coupled surface-emitting lasers. Opt Lett (1989) 0.75
Prescription-event monitoring of 10,895 patients treated with alprazolam. Br J Psychiatry (1991) 0.75
Importance of sampling both pulmonary veins in grading mitral regurgitation by transesophageal echocardiography. J Am Soc Echocardiogr (1993) 0.75
Nefazodone in community use: the results of prescription-event monitoring. Pharmacoepidemiol Drug Saf (1999) 0.75
Semiclassical theory of coupled lasers. Opt Lett (1984) 0.75
Group psychotherapy as an adjunct to lithium maintenance. Am J Psychiatry (1979) 0.75
Recursive numerical solution for nonlinear wave propagation in fibers and cylindrically symmetric systems. Appl Opt (1986) 0.75
Montelukast and improvement of eczema: observations from a prescription event monitoring study in England. Int J Clin Pharmacol Ther (2001) 0.75
Port-access cardiac surgery protocols and early outcomes. Crit Care Nurs Clin North Am (1998) 0.75